Rheumatology CME

Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Addressing the Burden of Polyarticular Juvenile Idiopathic Arthritis: A Roadmap to Improving Early Diagnosis and Treatment to Maximize Long-Term Outcomes
Daniel J. Lovell, MD, MPH
April 8, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis: Expert Insight on Clinical Decision-Making in an Expanding Therapeutic Landscape
Philip J. Mease, MD, MACR
March 4, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants: When Is It Appropriate to Implement Reversal Strategies in Patients With GI Bleeding?
Mark Crowther, MD, MSc, FRCPC, FRSC
January 26, 2021
Credits: 1.50 CME
Medical Learning Institute, Inc.
Precision Medicine in Hematologic Cancers: Lessons for Diagnostic and Treatment Protocols in CD30- and CD123-Expressing Disease
Steven M. Horwitz, MD
December 31, 2020
Credits: 0.25 CME
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
Bruce Cree, MD, PhD, MAS
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
John Ravits, MD
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Reducing the Burden of Chronic Rhinosinusitis With Nasal Polyps on Patient Quality of Life: An Exploration of Novel and Emerging Biologic Therapy
Jonathan Corren, MD
December 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
Sagar Lonial, MD, FACP
December 29, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes and Preventing Chronic Kidney Disease Progression: Evaluating the Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists
George L. Bakris, MD
December 29, 2020
Credits: 1.50 CME
Penn State College of Medicine
How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics
Tara Lin, MD
December 24, 2020
Credits: 1.50 CME
Penn State College of Medicine
Building New Management Models for NHL Care: Tumor Board Insights on Innovative Therapeutics in FL and DLBCL
Nathan H. Fowler, MD
December 23, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Preparing for Personalized Care in Myelodysplastic Syndromes: Integrating Innovative Treatments Into a Cohesive Patient Care Model
Steven D. Gore, MD
December 23, 2020
Credits: 1.25 CPE
Medical Learning Institute, Inc.
HIF-PH Inhibitors for Anemia in Chronic Kidney Disease: What Are Their Implications in Health-System Pharmacy?
December 22, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Making the Case for Treating Iron Deficiency in Patients With Heart Failure
Javed Butler, MD, MPH, MBA
December 9, 2020
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Personalizing and Prolonging Care in GIST: Expert Guidance on Integrating New TKI Strategies
Margaret von Mehren, MD
December 8, 2020
Credits: 0.50 CME / NCPD / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
Management of Hyperkalemia in Patients With Hemodialysis-Dependent Chronic Kidney Disease: Applying New Evidence and Best Practices for Improved Patient Outcomes
Steven Fishbane, MD
December 3, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
Suresh S. Ramalingam, MD, FACP, FASCO
November 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
Eric Gapud, MD, PhD
November 30, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Treatment Landscape of SSc-ILD: Strategies to Improve Recognition and Management
Flavia Castelino, MD
November 25, 2020
Credits: 1.50
PeerView Institute
Managed Care Implications of the Expanding Role of PARP Inhibitors in Oncology: Evolving Evidence Base, Current Value Assessment Frameworks, and Considerations for Decision-Making in Managed Care Settings
Kathleen N. Moore, MD, MS / Kristi Jhangiani, PharmD, BCPS
November 6, 2020
Credits: 1.50 CME
Penn State College of Medicine
Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment to Provide Optimal Care for Each Patient
Kenneth C. Kalunian, MD
September 18, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Overcoming Challenges in the Diagnosis and Management of Axial Spondyloarthritis: New Insights and Implications for Clinical Practice
Abhijeet Danve, MD, FACP, FACR
August 28, 2020
Credits: 0.50 CME / CNE / CE
Medical Learning Institute, Inc.
Mapping the Path to Better Patient Outcomes in Rheumatoid Arthritis and Psoriatic Arthritis: Need-to-Know Information and Practical Guidance About JAK Inhibitors for Advanced Practice Providers
Leonard H. Calabrese, DO
August 21, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
How I Think, How I Treat – Contemporary Insights on Diagnosing and Managing SSc-ILD in an Evolving Treatment Landscape
Lisa H. Lancaster, MD
August 19, 2020
Purdue University College of Pharmacy
Overcoming Challenges Associated With the Diagnosis and Management of EGPA: An Exploration of Novel Approaches
Praveen Akuthota, MD
February 18, 2020
Medical Learning Institute, Inc.
Recognizing and Managing Progressive Fibrosing ILD in Patients With Connective Tissue Diseases: Examining the Potential Clinical Implications of Antifibrotic Therapy
Lorinda Chung, MD, MS
December 10, 2019